Suppr超能文献

甲状腺癌中的增殖细胞核抗原/细胞周期蛋白(PCNA/Cyclin)

[Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].

作者信息

Xu Y J

机构信息

Hospital 309th of people's Liberation Army Beijing.

出版信息

Zhonghua Wai Ke Za Zhi. 1993 Oct;31(10):628-9.

PMID:7913437
Abstract

An immunohistochemical study of thyroid carcinoma using PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA/Cyclin), was performed on paraffin sections. There was significant difference statistically in PCNA index between any two types of all four types of thyroid carcinoma (P < 0.01), with the index of 35.36 +/- 9.59 in papillary carcinoma, 184.60 +/- 7.08 in follicular carcinoma, 392.43 +/- 31.66 in medullary carcinoma, and 488.28 +/- 19.93 in undifferentiated carcinoma. The results indicate that PCNA/Cyclin detection is a reliable method to examine the fraction of proliferating cells of thyroid carcinoma on paraffin sections, and it could be used to determine the prognosis of thyroid carcinoma.

摘要

利用抗增殖细胞核抗原(PCNA/细胞周期蛋白)的单克隆抗体PC10,对石蜡切片进行甲状腺癌的免疫组织化学研究。在所有四种类型的甲状腺癌中,任意两种类型之间的PCNA指数在统计学上均存在显著差异(P < 0.01),其中乳头状癌的指数为35.36 +/- 9.59,滤泡状癌为184.60 +/- 7.08,髓样癌为392.43 +/- 31.66,未分化癌为488.28 +/- 19.93。结果表明,PCNA/细胞周期蛋白检测是一种可靠的方法,可用于检测石蜡切片上甲状腺癌细胞的增殖分数,并可用于判断甲状腺癌的预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验